Status:

RECRUITING

Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)

Lead Sponsor:

Raincy Montfermeil Hospital Group

Collaborating Sponsors:

Janssen Cilag S.A.S.

Conditions:

Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Inflammatory Bowel Disease (IBD) is a chronic relapsing condition that affects the gastrointestinal tract and is increasingly diagnosed in adolescents and young adults. Although anti-TNFα therapies ar...

Eligibility Criteria

Inclusion

  • Adults aged 18 years and older
  • Diagnosis of Inflammatory Bowel Disease (IBD) established for at least 6 months
  • Patient is motivated to participate in the Adapted Physical Activity (APA) program
  • Medical certificate confirming fitness to engage in remote physical activity
  • Access to a digital device with internet connectivity enabling use of the MOOV+ application at home
  • Written informed consent freely given after appropriate information
  • Affiliation with, or beneficiary of, a national health insurance system

Exclusion

  • Patients under 18 years of age
  • Medical contraindication to physical activity
  • High levels of physical activity as defined by the International Physical Activity Questionnaire (IPAQ):
  • Total \>1500 MET-min/week of vigorous activity on at least 3 days, OR
  • Total physical activity \>3000 MET-min/week, regardless of distribution
  • Presence of psychological disorders that may interfere with study participation
  • Lack of access to a device or internet connection enabling remote participation
  • Pregnant or breastfeeding women
  • Patients under legal guardianship or curatorship
  • Patients under legal protection

Key Trial Info

Start Date :

September 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2026

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT07191106

Start Date

September 15 2025

End Date

March 31 2026

Last Update

September 24 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

GHI Le Raincy Montfermeil

Montfermeil, France, 93370

2

CHU Nantes

Nantes, France, 44093